
    
      The DIAMOND-AF study is a prospective, single blind, 1:1 randomized controlled study being
      performed at multiple centers in the United States, Canada and Europe. The study will
      evaluate the safety and effectiveness of the DiamondTemp System used for ablation in patients
      with paroxysmal atrial fibrillation (AF). Subjects will be randomized for treatment with
      either the DiamondTemp Ablation Catheter or the TactiCathâ„¢ Quartz Contact Force Ablation
      Catheter manufactured by Abbott. Patients will be followed for 12 months.
    
  